Free Access

Case—Idiopathic Pulmonary Fibrosis

David P. Kopcso
Corresponding Author
David P. Kopcso
[email protected]
Babson College, Wellesley, Massachusetts 02457
Search for more papers by this author
,
Howard Simon
Howard Simon
[email protected]
Babson College, Wellesley, Massachusetts 02457
Search for more papers by this author
,
Annie Gao
Annie Gao
[email protected]
Babson College, Wellesley, Massachusetts 02457
Search for more papers by this author

David P. Kopcso

Corresponding Author

David P. Kopcso

[email protected]

Babson College, Wellesley, Massachusetts 02457

Search for more papers by this author

,

Howard Simon

[email protected]

Babson College, Wellesley, Massachusetts 02457

Search for more papers by this author

,

Annie Gao

[email protected]

Babson College, Wellesley, Massachusetts 02457

Search for more papers by this author

Published Online:29 Apr 2016https://doi.org/10.1287/ited.2016.0155cs

References

DiMasi JA, Hansen RW, Grabowski HG (2003) The price of innovation: New estimates of drug development costs. J. Health Econom. 22(2):151–185.Crossref, Google Scholar

cover image INFORMS Transactions on Education

Volume 16, Issue 3

Teaching Healthcare Operations Research, Part 1

May 2016

Pages 85-111

Article Information

Metrics

Information

Received:January 01, 2015
Accepted:December 01, 2015
Published Online:April 29, 2016

Copyright © 2016, INFORMS

Cite as

David P. Kopcso, Howard Simon, Annie Gao (2016) Case—Idiopathic Pulmonary Fibrosis. INFORMS Transactions on Education 16(3):107-109.

https://doi.org/10.1287/ited.2016.0155cs

Keywords